Furthermore, the enhancement of tumor cell migration ability may be achieved by affecting the EMT, which process is dominated by NFE2L3, and knockdown of NFE2L3 inhibits Wnt/β-catenin signaling pathway. Here, NFE2L3 is linked to neoplasm.